Cutera

Cutera EBITDA Margin

Delisted

The EBITDA Margin of Cutera (CUTRQ) as of Nov 10, 2026 is -73.57 %. In the previous year, EBITDA Margin was -15.13 % — a change of 386.07% (lower).

EBITDA Margin

-73.57 %

YoY

386.07%

Last updated:

EBITDA Margin of Cutera is 2023 -73.57 % . EBITDA Margin of Cutera was 2022 -15.13 % . It decreases by 386.07% lower compared to the previous year.

The Cutera EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2016
2.03 USD
Jan 1, 2017
4.69 USD
Jan 1, 2018
-8.24 USD
Jan 1, 2019
-6.66 USD
Jan 1, 2020
-15.44 USD
Jan 1, 2021
0.86 USD
Jan 1, 2022
-15.13 USD
Jan 1, 2023
-73.57 USD
The Cutera EBITDA Margin history
YEAREBITDA MarginYoY
-73.57 %+386.07%
-15.13 %-1,850.33%
0.86 %-105.60%
-15.44 %+131.81%
-6.66 %-19.14%
-8.24 %-275.74%
4.69 %+130.61%
2.03 %-142.81%
-4.75 %-65.03%
-13.57 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cutera Stock analysis

What does Cutera do? Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. The company was founded in California in 1998 and has since had a successful history in the beauty and medical care industry. Cutera's business model consists of developing and selling innovative laser devices used in the cosmetics and medical industries. The company's goal is to offer its customers (doctors, beauty clinics, etc.) the latest and most effective laser technologies to meet the needs and expectations of their patients. In recent years, Cutera has focused on several areas to offer its customers a wider range of products. These include skin rejuvenation, body contouring, hair removal, vascular and pigmented lesions, scar treatment, and tattoo removal. The company has over 20 different products in its portfolio, all tailored to the needs of different patient groups. In the field of skin rejuvenation, Cutera offers variants such as Laser Genesis Plus, Genesis V, Excel HR, and other lasers to treat wrinkles, fine lines, pigment irregularities, and texture problems. Body contouring is made possible through devices such as Sculpture and TruSculpt 3D. Hair removal is supported by the ProWave, CoolGlide, and XEO system. Treatment of vascular and pigmented lesions is done through devices such as Excel HR, LimeLight, and the XEO system. For scar treatment and tattoo removal, lasers such as Enlighten and Genesis V are used. Cutera has gained an excellent reputation in the industry through its innovative products and sustainable business philosophy. The company aims to meet the needs and expectations of its customers by providing innovative technologies, high-quality products, and outstanding customer service. Cutera continually invests in research and development to ensure that it can always offer its customers the latest and best laser devices. Additionally, the company places great importance on the safety of its products and has specialized in training and education for its customers and users. Recently, Cutera Inc. has also made strides in telemedicine to better support its customers. This allows doctors and users to access support anytime and anywhere, for example, for training and technical support. In summary, Cutera Inc. is a leading company in the field of aesthetic and medical laser technology. Its wide range of products tailored to the different needs and expectations of patients has earned it an excellent reputation in the industry. Cutera continuously invests in research and development, offers outstanding customer service, and places great importance on the safety of its products. In the future, the company will continue to develop innovative technologies, revolutionizing beauty and medical care. Cutera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cutera stock

EBITDA Margin of Cutera is -73.57 % in 2023.

EBITDA Margin of Cutera changed from -15.13 % to -73.57 %, representing a 386.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Cutera since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Cutera with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Cutera

All Key Metrics — Cutera